Advertisement
Screener

Nexalin Technology, Inc. (NXL) Unrealized Gain (Loss) on Investments

1.8 / 5 stars · 14/38 Roast Me

Nexalin Technology, Inc. Unrealized Gain (Loss) on Investments

Nexalin Technology, Inc. (NXL) reported Unrealized Gain (Loss) on Investments of -$406 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-12

  • Nexalin Technology, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$406.00, a 179.14% decline year-over-year.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was $88.00, a 89.40% decline year-over-year.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $1.04K.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was -$1.46K.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for fiscal 2025 was $919.00.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for fiscal 2024 was -$108.00.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for fiscal 2023 was -$36.72K, a 201.12% decline from fiscal 2022.
  • Nexalin Technology, Inc. unrealized gain (loss) on investments for fiscal 2022 was $36.31K.
Period endUnrealized Gain (Loss) on Investments 3 monthUnrealized Gain (Loss) on Investments 6 monthUnrealized Gain (Loss) on Investments 9 monthUnrealized Gain (Loss) on Investments 12 month
2026-06-30-$406.00
10-Q · filed 2026-08-12
-$494.00
10-Q · filed 2026-08-12
$720.00
derived: sum of 3 quarters · filed 2026-08-12
-$741.00
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$88.00
10-Q · filed 2026-05-08
$1.13K
derived: sum of 2 quarters · filed 2026-05-08
-$335.00
derived: sum of 3 quarters · filed 2026-05-08
$178.00
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$1.04K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$423.00
derived: sum of 2 quarters · filed 2026-03-25
$90.00
derived: sum of 3 quarters · filed 2026-08-12
$919.00
10-K · filed 2026-03-25
2025-09-30-$1.46K
10-Q · filed 2025-11-14
-$948.00
derived: sum of 2 quarters · filed 2026-08-12
-$119.00
10-Q · filed 2025-11-14
-$306.00
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$513.00
10-Q · filed 2026-08-12
$1.34K
10-Q · filed 2026-08-12
$1.16K
derived: sum of 3 quarters · filed 2026-08-12
$830.00
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$830.00
10-Q · filed 2026-05-08
$642.00
derived: sum of 2 quarters · filed 2026-05-08
$317.00
derived: sum of 3 quarters · filed 2026-05-08
$562.00
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$188.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$513.00
derived: sum of 2 quarters · filed 2026-03-25
-$268.00
derived: sum of 3 quarters · filed 2026-03-25
-$108.00
10-K · filed 2026-03-25
2024-09-30-$325.00
10-Q · filed 2025-11-14
-$80.00
derived: sum of 2 quarters · filed 2025-11-14
$80.00
10-Q · filed 2025-11-14
-$1.13K
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$245.00
10-Q · filed 2025-08-06
$405.00
10-Q · filed 2025-08-06
-$800.00
derived: sum of 3 quarters · filed 2025-09-23
-$33.09K
derived: sum of 4 quarters · filed 2025-09-23
2024-03-31$160.00
10-Q · filed 2025-05-13
-$1.04K
derived: sum of 2 quarters · filed 2025-09-23
-$33.33K
derived: sum of 3 quarters · filed 2025-09-23
-$41.31K
derived: sum of 4 quarters · filed 2025-09-23
2023-12-31-$1.21K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23
-$33.49K
derived: sum of 2 quarters · filed 2025-09-23
-$41.47K
derived: sum of 3 quarters · filed 2025-09-23
-$36.72K
10-K/A · filed 2025-09-23
2023-09-30-$32.29K
10-Q · filed 2024-11-08
-$40.27K
derived: sum of 2 quarters · filed 2024-11-08
-$35.51K
10-Q · filed 2024-11-08
2023-06-30-$7.98K
10-Q · filed 2024-08-08
-$3.22K
10-Q · filed 2024-08-08
2023-03-31$41.07K
10-Q · filed 2024-05-10
2022-12-31$36.31K
10-K · filed 2024-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuraxis, INC (NRXS)United States$0.097B
Streamex Corp. (STEX)United States$0.089B-0.19
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B